Mizuho Securities analyst Anthony Petrone has maintained their bullish stance on INSP stock, giving a Buy rating yesterday. Anthony ...

Inspire Medical Systems (INSP – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst ...

Inspire Medical Systems topped Q3 expectations, signaling continued market strength and innovation.

Do you suffer from sleep apnea and long for a peaceful night’s sleep and solution to your snoring? Holy Cross Medical Group pulmonologist Ronald Scott, M.D. will speak about Inspire®, an FDA-approved ...

Sleep apnea is a disorder that involves pauses in breathing during sleep. Three main types exist: obstructive, central, and complex. Each is defined and treated based on its underlying cause.

Inspire Medical Systems shares are up today on third-quarter results that came in ahead of the consensus forecast.

Inspire is a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea. Inspire’s ...

Inspire is a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea. Inspire's proprietary ...

(Inspire, or the company), a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea ...

Inspire expects full-year earnings to be $1.20 to $1.40 per share, with revenue in the range of $793 million to $798 million. This story was generated by Automated Insights ( ...

(Inspire, or the company), a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea, today ...